{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:01:39Z","timestamp":1785211299198,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpx.2026.100551","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:49:02Z","timestamp":1777214942000},"page":"100551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spray-freeze-drying aprepitant with hydroxypropyl cellulose increases nasal bioavailability"],"prefix":"10.1016","volume":"11","author":[{"given":"Annika","family":"Rautenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"B\u00fchlbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ko\u017e\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Pellequer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wunderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmont","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100551_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12249-025-03117-4","article-title":"Freeze-Drying as a tool for preparing porous materials: from proof of concept to recent pharmaceutical applications","volume":"26","author":"Abla","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100551_bb0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejpb.2014.03.009","article-title":"Spray freeze drying for dry powder inhalation of nanoparticles","volume":"87","author":"Ali","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2016.11.023","article-title":"Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles","volume":"516","author":"Ali","year":"2017","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0020","article-title":"In vitro and in vivo assessment of hydroxypropyl cellulose as functional additive for enabling formulations containing itraconazole","volume":"3","author":"Bachmaier","year":"2021","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100551_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124009","article-title":"Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2","volume":"655","author":"Baldelli","year":"2024","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0030","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2165\/11203680-000000000-00000","article-title":"Aprepitant","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ijpx.2026.100551_bb0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jps.20331","article-title":"Pharmaceutical development of a Lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent","volume":"94","author":"Den Brok","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144472","article-title":"Dimethyl sulfoxide: a Bio-Friendly or Bio-Hazard chemical? The effect of DMSO in human fibroblast-like synoviocytes","volume":"27","author":"Gallardo-Villagr\u00e1n","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100551_bb0045","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J. Anat."},{"key":"10.1016\/j.ijpx.2026.100551_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.05961.x","article-title":"Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting","volume":"1222","author":"Hargreaves","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0055","series-title":"ICH Harmonised Guideline - Impurities: Guideline for Residual Solvents Q3C(R8)","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100551_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112350","article-title":"Development of in vitro evaluation system for assessing drug dissolution considering physiological environment in nasal cavity","volume":"14","author":"Inoue","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100551_bb0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9610(67)90166-3","article-title":"Dimethyl sulfoxide (DMSO) toxicology, pharmacology, and clinical experience","volume":"114","author":"Jacob","year":"1967","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ijpx.2026.100551_bb0070","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.12688\/f1000research.16642.1","article-title":"Adverse reactions of dimethyl sulfoxide in humans: a systematic review","volume":"7","author":"Kollerup Madsen","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.ijpx.2026.100551_bb0075","series-title":"Spray-Freeze-Dried Microspheres for Delivery and Stabilization of Cannabis Sativa Extract","author":"Ko\u017e\u00e1k","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100551_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122235","article-title":"Rivaroxaban lyospheres prepared by a dimethyl sulfoxide-based spray-freeze-drying process","volume":"627","author":"Ko\u017e\u00e1k","year":"2022","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107220","article-title":"Hydroxypropyl cellulose-based lyospheres accelerate dissolution of aprepitant combined with its supersaturation for oral delivery","volume":"213","author":"Ko\u017e\u00e1k","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s42238-025-00381-w","article-title":"Combined extraction and spray-freeze-drying of Cannabis sativa Flos provides stable lyophilizate particles of cannabinoids","volume":"8","author":"Ko\u017e\u00e1k","year":"2026","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ijpx.2026.100551_bb0095","series-title":"Toxicological Review of Tert-Butyl Alcohol (Tert-Butanol)","author":"Lee","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100551_bb0100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1208\/s12249-013-9960-2","article-title":"Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions","volume":"14","author":"Liu","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100551_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejpb.2022.03.007","article-title":"Designing highly porous amorphous celecoxib particles by spray freeze drying leads to accelerated drug absorption in-vivo","volume":"174","author":"Lucas","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0110","first-page":"431","article-title":"Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery","volume":"37","author":"Maher","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ijpx.2026.100551_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/anie.196703181","article-title":"The solvent dimethyl sulfoxide","volume":"6","author":"Martin","year":"1967","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100551_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","article-title":"Cyclodextrins in nasal drug delivery","volume":"36","author":"Merkus","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ijpx.2026.100551_bb0120","first-page":"13","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv Rev."},{"key":"10.1016\/j.ijpx.2026.100551_bb0130","article-title":"Enabling formulations of aprepitant: in vitro and in vivo comparison of nanocrystalline, amorphous and deep eutectic solvent based formulations","volume":"3","author":"Palmelund","year":"2021","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100551_bb0135","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3109\/03639045.2016.1160105","article-title":"Hot melt extruded Aprepitant\u2013Soluplus solid dispersion: preformulation considerations, stability and in vitro study","volume":"42","author":"Penumetcha","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0140","article-title":"Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1: 1) and hydroxypropyl cellulose in ternary amorphous solid dispersions","volume":"4","author":"P\u00f6stges","year":"2022","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100551_bb0145","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1080\/03639045.2017.1321659","article-title":"Development of a soluplus budesonide freeze-dried powder for nasal drug delivery","volume":"43","author":"Pozzoli","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpharm.2015.02.035","article-title":"Identifying the mechanisms of drug release from amorphous solid dispersions using MRI and ATR-FTIR spectroscopic imaging","volume":"483","author":"Pun\u010dochov\u00e1","year":"2015","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2022.117905","article-title":"Spray-freeze-dried lyospheres: solid content and the impact on flowability and mechanical stability","volume":"411","author":"Rautenberg","year":"2022","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpx.2026.100551_bb0160","series-title":"Drug Delivery to the Lungs Conference Proceedings","first-page":"35","article-title":"High nasal deposition and controlled dissolution of spray freeze dried melatonin powders","author":"Rautenberg","year":"2024"},{"key":"10.1016\/j.ijpx.2026.100551_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2025.121400","article-title":"Understanding fragility and cohesiveness in spray freeze-dried powders","volume":"466","author":"Rautenberg","year":"2025","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpx.2026.100551_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2026.140304","article-title":"Systematic investigation of thermal process parameters on the morphology of spray-freeze-dried powders","author":"Rautenberg","year":"2026","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100551_bb0180","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/pharmaceutics13060852","article-title":"Spray freeze dried Lyospheres\u00ae for nasal administration of insulin","volume":"13","author":"Serim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100551_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2010.05.009","article-title":"Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans","volume":"76","author":"Shono","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.colsurfb.2016.01.063","article-title":"Collisions and coalescence in droplet streams for the production of freeze-dried powders","volume":"141","author":"S\u00fcverkr\u00fcp","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100551_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/03639045.2020.1716367","article-title":"Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology","volume":"46","author":"Tanaka","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100551_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","article-title":"Opportunity and challenges of nasal powders: Drug formulation and delivery","volume":"113","author":"Tiozzo Fasiolo","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0205","article-title":"Amorphous solid dispersion formation via solvent granulation \u2013 a case study with ritonavir and Lopinavir","volume":"1","author":"Trasi","year":"2019","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100551_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.04.053","article-title":"Pharmaceutical spray freeze drying","volume":"488","author":"Wanning","year":"2015","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123896","article-title":"Development of favipiravir dry powders for intranasal delivery: an integrated cocrystal and particle engineering approach via spray freeze drying","volume":"653","author":"Wong","year":"2024","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103795","article-title":"Intranasal delivery of temozolomide and desloratadine for brain tumour therapy: a cellular study on nasal epithelial toxicity, transport, and permeability","volume":"114","author":"Wong","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100551_bb0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2004.08.001","article-title":"The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a beagle dog model predicts improved bioavailability and diminished food effect on absorption in human","volume":"285","author":"Wu","year":"2004","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpx.2026.100551_bb0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/iju.14505","article-title":"Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis\/bladder pain syndrome in Japanese patients: a multicenter, randomized, double-blind, placebo-controlled, clinical study","volume":"28","author":"Yoshimura","year":"2021","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ijpx.2026.100551_bb0235","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s11095-024-03770-7","article-title":"Fabrication of uniform melatonin microparticles potentially for nasal delivery: a comparison of spray drying and spray freeze drying","volume":"41","author":"You","year":"2024","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:39:06Z","timestamp":1785209946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259015672600071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S259015672600071X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100551","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spray-freeze-drying aprepitant with hydroxypropyl cellulose increases nasal bioavailability","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100551"}}